Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd Share Price (KILITCH)

₹347.850.87%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Kilitch Drugs (India) Ltd share Performance

  • ₹340
    ₹357.95
    ₹347.85
    downward going graph

    2.26%

    Low

    Day's Volatility:5.16%

    High

    2.90%

    downward going graph
  • ₹159
    ₹470
    ₹347.85
    downward going graph

    54.29%

    Low

    52 Weeks Volatility:89.41%

    High

    35.12%

    downward going graph
1 Month Return-1.5 %
3 Month Return-11.2 %
1 Year Return111.64 %
Previous Close₹350.90
Open₹350.00
Volume5,437.00
Upper Circuit-
Lower Circuit-
Market Cap₹564.33Cr

Company Information

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Share Price: ₹347.85 per share as on 19 Apr, 2024 04:01 PM
Market Capitalisation: ₹564.33Cr as of today
Revenue: ₹31.79Cr as on December 2023 (Q4 23)
Net Profit: ₹1.74Cr as on December 2023 (Q4 23)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Kilitch Drugs (India) Ltd

  • Kilitch Healthcare India Receives Warning Letter from USFDA - 12 Apr, 2024

    The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses, including packing drugs in insanitary conditions at its Maharashtra-based plant. The Navi-Mumbai plant produces finished pharmaceuticals.

  • Kilitch Healthcare India Receives Warning Letter from USFDA - 11 Apr, 2024

    The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for significant violations of current good manufacturing practice regulations, including packing drugs in insanitary conditions at its Maharashtra-based plant.

Fundamentals of Kilitch Drugs (India) Ltd

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 30.77% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.23% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, KILITCH stock has moved down by -1.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 4.74 Cr → 2.91 Cr (in ₹), with an average decrease of 38.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 41.69 Cr → 34.75 Cr (in ₹), with an average decrease of 16.7% per quarter

Kilitch Drugs (India) Ltd Valuation

Kilitch Drugs (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (38.06x)

April 18, 2024

Industry (61.24x)

April 18, 2024

Highest (363.79x)

October 16, 2020

LowHigh

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
69.23%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
30.77%
0.00
Others
0%
0.00

Technicals of Kilitch Drugs (India) Ltd share

News & Events of Kilitch Drugs (India) Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Kilitch Drugs (India) Ltd shares.

Kilitch Drugs (India) Ltd (KILITCH) share price today is ₹347.85

Kilitch Drugs (India) Ltd is listed on NSE

Kilitch Drugs (India) Ltd is listed on BSE

  • Today’s highest price of Kilitch Drugs (India) Ltd is ₹357.95.
  • Today’s lowest price of Kilitch Drugs (India) Ltd is ₹340.

PE Ratio of Kilitch Drugs (India) Ltd is 38.06

PE ratio = Kilitch Drugs (India) Ltd Market price per share / Kilitch Drugs (India) Ltd Earnings per share

Today’s traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 5,437.00.

Today’s market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹564.33Cr.

Kilitch Drugs (India) Ltd(KILITCHPrice
52 Week High
₹470
52 Week Low
₹159

Kilitch Drugs (India) Ltd(KILITCH) share price is ₹347.85. It is down -25.99% from its 52 Week High price of ₹470

Kilitch Drugs (India) Ltd(KILITCH) share price is ₹347.85. It is up 118.77% from its 52 Week Low price of ₹159

Kilitch Drugs (India) Ltd(KILITCHReturns
1 Day Returns
-3.05%
1 Month Returns
-1.5%
3 Month Returns
-11.2%
1 Year Returns
111.64%